Bank of America’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-338
Closed -$1.23K 8476
2024
Q2
$1.23K Buy
338
+5
+2% +$26 ﹤0.01% 7198
2024
Q1
$2.64K Sell
333
-1
-0.3% -$8 ﹤0.01% 7092
2023
Q4
$2.4K Buy
334
+1
+0.3% +$11 ﹤0.01% 7113
2023
Q3
$6.24K Hold
333
﹤0.01% 6943
2023
Q2
$9.48K Hold
333
﹤0.01% 6878
2023
Q1
$18.6K Sell
333
-2
-0.6% -$71 ﹤0.01% 6773
2022
Q4
$7.23K Sell
335
-35
-9% -$951 ﹤0.01% 6987
2022
Q3
$11K Buy
370
+303
+452% +$10.7K ﹤0.01% 7213
2022
Q2
$2K Sell
67
-2,347
-97% -$162K ﹤0.01% 7806
2022
Q1
$233K Buy
2,414
+2,111
+697% +$320K ﹤0.01% 6384
2021
Q4
$59K Buy
303
+275
+982% +$42.8K ﹤0.01% 7145
2021
Q3
$6K Buy
+28
New +$7.11K ﹤0.01% 7706

Other funds holding TBIO

Bank of America's TBIO Position: Q3 2024 in Review

Bank of America sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 338 shares — an estimated $1.23K sold.

Bank of America first reported a position in TBIO in Q3 2021 and held it in 12 quarters. The position peaked at $233K in Q1 2022. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

  • Bank of America reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Bank of America sold 338 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $1.23K.
  • Bank of America first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
  • Bank of America's Telesis Bio, Inc. Common Stock position peaked at $233K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.